drugset / Trial / NCT03101293

A Study to Evaluate the Effect of Food on the Pharmacokinetics of TAK-831 Tablet Formulation

NCT03101293 ↗

Phase 1 Completed 15 enrolled Neurocrine Biosciences Takeda · collab
RandomizedCrossoverOpen-labelOther

Summary

The purpose of this study is to determine the pharmacokinetic (PK) of a single oral dose of TAK-831 400 milligram (mg) in the fasted state and to estimate the effect of food on the PK of a single oral dose of TAK-831 400 mg when administered as tablet formulation in healthy participants.

Timeline

Start
2017-04-04
Primary completion
2017-05-19
Completion
2017-05-26

Drugs

EvaluationDrugModalityDoseRoute
Subject Luvadaxistat Small molecule 400 mg Oral

Indications

No indication recorded.